Lataa...
Lurasidone inhibits NMDA receptor antagonist‐induced functional abnormality of thalamocortical glutamatergic transmission via 5‐HT(7) receptor blockade
BACKGROUND AND PURPOSE: Lurasidone is an atypical mood‐stabilizing antipsychotic with a unique receptor‐binding profile, including 5‐HT(7) receptor antagonism; however, the detailed effects of 5‐HT(7) receptor antagonism on various transmitter systems relevant to schizophrenia, particularly the thal...
Tallennettuna:
| Julkaisussa: | Br J Pharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6811777/ https://ncbi.nlm.nih.gov/pubmed/31347694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14804 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|